Erbitux add-on falls short in esophageal cancer
Source: www.medpagetoday.com Author: Charles Bankhead, Staff Writer, MedPage Today The addition of a targeted agent to definitive chemoradiation failed to improve [...]
If you didn't find what you were looking for, try a new search!
Source: www.medpagetoday.com Author: Charles Bankhead, Staff Writer, MedPage Today The addition of a targeted agent to definitive chemoradiation failed to improve [...]
Source: The ASCO Post, January 1, 2012, Volume 3, Issue 1, Matthew Stenger In the Clinic provides overviews of novel oncology agents, [...]
Source: www.pharmabiz.com Author: staff The US Food and Drug Administration (FDA) has approved Erbitux (cetuximab), in combination with platinum-based chemotherapy with [...]
Source: Gastroenterology & Endoscopy News Hypersensitivity reactions to cetuximab (Erbitux, ImClone Systems/Bristol-Myers Squibb), a monoclonal antibody approved for use in colorectal [...]
Source: professional.cancerconsultants.com Author: staff A multicenter randomized trial has shown that patients with locoregionally advanced head and neck cancer receiving adjuvant [...]
Source: www.vwd.de Author: press release The American Society of Clinical Oncology (ASCO) has once again recognized Erbitux® (cetuximab) as one of [...]
Source: professional.cancerconsultants.com Author: staff Researchers from Germany have reported that Erbitux® (cetuximab) improves response rate, time to disease progression, and overall [...]
Source: www.bloomberg.com Author: Lisa Rapaport Eli Lilly & Co.’s tumor-fighter Erbitux doesn’t prolong lung cancer patients’ lives enough to justify its [...]
Source: Bloomberg Author: Lisa Rapaport Eli Lilly & Co.’s tumor-fighter Erbitux doesn’t prolong lung cancer patients’ lives enough to justify its [...]
Source: Pharmafocus.com Author: Staff Erbitux has failed to win NICE approval for the treatment of head and neck cancer, due to [...]
Source: www.reuters.com Author: Ransdell Pierson U.S. regulators have declined to approve use of Erbitux as a first-line treatment for head and [...]
Source: www.newsinferno.com Author: staff Combining Avastin and Erbitux with chemotherapy to treat colon cancer may actually make patients sicker, and cause [...]
Source: www.medadnews.com Author: press release Today leading oncology specialists and media gathered at the Antwerp University Hospital to mark the European [...]
Source: www.rttnews.com Author: staff Imclone Systems Inc. and Bristol-Myers Squibb Co. announced that the supplemental biological license application seeking expanded approval [...]
Source: www.medicalnewstoday.com Author: staff Merck Serono's Erbitux® is one of the finalists for the prestigious International Prix Galien Award for excellence [...]